Matched pair antibodies and OEM kits for lateral flow food allergen testing
Leinco Technologies supplies matched pair antibodies for food allergen detection in lateral flow assays (LFAs), along with finished kits and test strips. With over 30 years of antibody manufacturing experience, Leinco offers catalog and custom antibody solutions already validated in commercial diagnostic kits, supporting rapid test development for food safety applications.
Overview
Leinco Technologies provides matched pair antibodies specifically suited for lateral flow assay (LFA) development targeting food allergens. These antibodies are already incorporated into validated commercial diagnostic kits, giving partners a proven starting point for food allergen testing. Beyond raw antibody supply, Leinco offers finished kits, test strips, and OEM products, enabling partners to choose between integrating antibodies as raw materials into their own assay development or purchasing complete kits.
With more than 30 years of experience in antibody and protein manufacturing, Leinco supports partners across the diagnostics value chain. The company develops hybridomas, creates recombinant antibodies and proteins, and assists with assay validation. Leinco's manufacturing facility in Fenton, Missouri, operates under ISO 9001:2015 certification, supporting both small-scale research and large-scale production needs.
Technical specifications
Core capabilities:
- Matched pair antibody development for food allergen targets, validated for use in lateral flow assays
- Hybridoma development and recombinant antibody and protein production
- Assay validation support, including testing antibodies to confirm matched pair performance and providing supporting data
- Finished products including lateral flow kits, test strips, and OEM kit options
- Licensing of clones and partnership with research institutions
- ISO 9001:2015 certified manufacturing facility supporting scalable production
Key advantages:
- Antibodies already proven in commercial diagnostic kits, reducing development risk
- Flexible engagement models: raw material supply, custom development, or OEM kit purchase
- CDMO capabilities spanning antigen design, gene synthesis, stable cell line generation, and protein expression
Technology readiness level
These are existing, commercially validated products. The matched pair antibodies have already been incorporated into commercial lateral flow kits, though specific customer identities are protected under non-disclosure agreements. Leinco can provide data sheets for its antibody products to support partner evaluation and integration. The remaining validation steps depend on the partner's chosen pathway, whether conducting independent assay development using Leinco's antibodies as raw materials or purchasing OEM kits for direct deployment.
About Leinco T
Leinco Technologies is a biotechnology company founded in 1992 that specializes in the research, development, and manufacturing of high-quality antibodies and recombinant proteins. The company provides an extensive product catalog, including monoclonal and polyclonal antibodies, ELISA kits, and various reagents for applications such as flow cytometry, immunohistochemistry, and western blotting. Beyond its catalog products, Leinco operates as a contract development and manufacturing organization (CDMO), offering tailored services that range from antigen design and gene synthesis to stable cell line generation, protein expression, and custom antibody engineering. Their manufacturing facility in Fenton, Missouri, is ISO 9001:2015 certified, supporting both small-scale research needs and large-scale production requirements.
These products and services serve as essential tools for scientists in life sciences discovery, diagnostics, and biopharmaceutical development. By focusing on high-purity, low-cross-reactivity products—such as their functional grade antibodies for in vivo studies and biosimilars for therapeutic research—Leinco enables researchers to generate reproducible and reliable data. The company acts as a collaborative partner for laboratories and biopharma firms, utilizing consultative expertise to help clients navigate the complexities of antibody development and protein production, ultimately accelerating the path from early discovery to clinical diagnostics and therapeutic applications.
delivered to your inbox.